SOLI: SEC Suspension "because of questions regarding the accuracy and adequacy of information in the marketplace since at least March 16, 2020. Those questions relate to statements SOLI made, in a press release issued by the Company on March 16, 2020 and a March 18, 2020 national cable news program interview with the Chief Executive Officer of its wholly-owned subsidiary, CareClix, Inc., about the ability of CareClix to provide COVID-19 testing kits that would allow a patient to submit a testing sample from home."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.